Quest Diagnostics (NY:DGX)

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗

What's going on in today's session: S&P500 movers ↗

Today 15:05 EST

Via Chartmill

Today 13:05 EST

Via Chartmill

Stay informed with the top movers within the S&P500 index on Tuesday. ↗

Today 12:35 EST

Via Chartmill

Quest Diagnostics Inc (NYSE:DGX) Beats Q4 Estimates, Announces Dividend Hike and $1B Buyback ↗

Today 7:21 EST

Via Chartmill

Quest Diagnostics Inc (NYSE:DGX) Offers a Reliable Dividend with Strong Growth and Profitability ↗

February 07, 2026

Via Chartmill

Quest Diagnostics Inc. (NYSE:DGX): A Prime Pick for Steady, Growing Dividends ↗

January 15, 2026

Via Chartmill

Quest Diagnostics (DGX) Earnings Call Transcript ↗

Today 11:31 EST

Quest Diagnostics (DGX) Earnings Call Transcript

Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) announced better-than-expected revenue in Q4 CY2025, with sales up 7.1% year on year to $2.81 billion. The company’s full-year revenue...

Topics Earnings

Quest’s (NYSE:DGX) Q4 CY2025: Beats On Revenue

Today 6:58 EST

Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) will be announcing earnings results this Tuesday morning. Here’s what you need to know.

Quest (DGX) Q4 Earnings: What To Expect

February 08, 2026

This genomics stock appears to be at an inflection point.

Topics Artificial Intelligence World Trade

Should You Buy Guardant Health Before Feb. 19? ↗

January 30, 2026

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps...

Topics Earnings

January 18, 2026

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from...

3 Mid-Cap Stocks We Find Risky

January 14, 2026

Quest trades at $179.96 and has moved in lockstep with the market. Its shares have returned 6.9% over the last six months while the S&P 500 has gained 11.3%.

3 Reasons to Sell DGX and 1 Stock to Buy Instead

January 13, 2026

GRAIL Surges as Canaccord Genuity Sets Ambitious $105 Price Target Following Robust 2025 Growth

Topics Stocks

January 13, 2026

In a resounding vote of confidence for the future of multi-cancer early detection (MCED), Canaccord Genuity reiterated its "Buy" rating for GRAIL (Nasdaq: GRAL) on Tuesday, January 13, 2026, setting an...

Q3 Earnings Highlights: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks

January 01, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q3, starting...

Quest Diagnostics (DGX) offers a reliable dividend with a strong yield, backed by consistent growth, solid profitability, and a sustainable payout ratio for income investors.

Quest Diagnostics Inc. (NYSE:DGX) Stands Out as a Dependable Dividend Stock ↗

December 16, 2025

Via Chartmill

1 S&P 500 Stock to Target This Week and 2 We Brush Off

December 11, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Quest (DGX) Q3 2025 Earnings Call Transcript

Topics Stocks

Quest (DGX) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Quest Diagnostics (DGX) offers a strong dividend profile with a 1.71% yield, steady growth, and a sustainable payout, backed by solid profitability and financial health.

Topics Earnings

Quest Diagnostics Inc (NYSE:DGX) Presents a Strong Case for Dividend Investors ↗

November 22, 2025

Via Chartmill

Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut.

Hims & Hers launches Labs, offering annual biomarker testing plans with doctor-developed guidance and expanded diagnostics planned across key health categories.

Topics Economy

Hims & Hers Introduces Labs With Annual Plans For Comprehensive Testing ↗

November 14, 2025

Via Benzinga

Quest Diagnostics Solidifies Shareholder Value with $0.80 Quarterly Dividend

November 11, 2025

Securing Shareholder Returns in a Dynamic Healthcare Landscape Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, has declared a quarterly cash dividend of $0.80 per...

Quest Diagnostics (NYSE: DGX) Bolsters Shareholder Confidence with Latest Dividend Declaration

November 11, 2025

Secaucus, NJ – November 11, 2025 – Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, has declared a quarterly cash dividend of $0.80 per share, reaffirming its...

Economic Crossroads: How Key Indicators Are Steering the Stock Market Through Moderation and Policy Shifts

November 05, 2025

The financial markets are currently navigating a complex and often contradictory economic landscape, heavily influenced by a suite of critical indicators such as jobs data and the Purchasing Managers'...

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Topics Artificial Intelligence Economy Immigration

3 Low-Volatility Stocks We Think Twice About

November 02, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This...

3 Healthcare Stocks We Steer Clear Of

October 31, 2025

The healthcare company's innovative cancer tests are helping to save lives.

Topics Stocks

Why Guardant Health Stock Surged Today ↗

October 30, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Price Over Earnings Overview: Quest Diagnostics ↗

October 24, 2025

Via Benzinga

1 Profitable Stock to Target This Week and 2 Facing Challenges

October 24, 2025